Our aim was to determine the initial technical feasibility, clinical safety, and efficacy of the SAPIEN M3 System in patients with severe mitral regurgitation (MR). Mitral valve surgery is currently… Click to show full abstract
Our aim was to determine the initial technical feasibility, clinical safety, and efficacy of the SAPIEN M3 System in patients with severe mitral regurgitation (MR). Mitral valve surgery is currently recommended in patients with severe, symptomatic MR. The SAPIEN M3 System is a novel, transvenous,
               
Click one of the above tabs to view related content.